Renin-angiotensin system blockers and COVID-19

BMC Medicine

Emmanuelle Vidal-Petiot¹  Nathalie Gault² 

[1]Assistance Publique-Hôpitaux de Paris, Physiology department, Bichat-Claude Bernard University Hospital, 46 rue Henri Huchard, Paris, France

[2]Université de Paris, Inserm U1149, 75018, Paris, France

[3]INSERM CIC-EC 1425, hôpital Bichat Claude Bernard, 75018, Paris, France

[4]APHP.Nord, Département Epidémiologie Biostatistiques et Recherche Clinique, Hôpital Bichat, 75018, Paris, France

关键词: SARS-CoV-2;    COVID-19;    Renin-angiotensin-aldosterone system;    RAS blockers;    Angiotensin-converting enzyme inhibitors;    Angiotensin receptor blockers;   

DOI  :  10.1186/s12916-021-02012-6

来源: Springer

【 授权许可】

CC BY